Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (271-280 of 354) with videos related to

Pageof 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and DecitabineEvan C Chen, Yiwen Liu, Hayden L Bell, et al.
Genome Research|July 7, 2017
Integrated single-cell genetic and transcriptional analysis suggests novel drivers of chronic lymphocytic leukemiaLili Wang, Jean Fan, Joshua M Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2007
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphomaMichael J Robertson, Brad S Kahl, Julie M Vose, et al.
Blood Advances|January 26, 2022
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapyJurjen Versluis, Manu Pandey, Yael Flamand, et al.
Blood|November 20, 2004
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory responseStefano Monti, Kerry J Savage, Jeffery L Kutok, et al.
Cancer Cell|February 16, 2005
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-AblEllen Weisberg, Paul W Manley, Werner Breitenstein, et al.
American Journal of Hematology|December 25, 2015
Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remissionMatthew D Seftel, Donna Neuberg, Mei-Jie Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibilityJennifer L Shepard, James F Amatruda, Howard M Stern, et al.
JAMA Oncology|February 26, 2016
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and VulvaBrooke E Howitt, Heather H Sun, Margaretha G M Roemer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers NetworkGuray Akturk, Edwin R Parra, Evisa Gjini, et al.
Pageof 36

Showing results (271-280 of 354) with videos related to

Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and DecitabineEvan C Chen, Yiwen Liu, Hayden L Bell, et al.
Genome Research|July 7, 2017
Integrated single-cell genetic and transcriptional analysis suggests novel drivers of chronic lymphocytic leukemiaLili Wang, Jean Fan, Joshua M Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2007
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphomaMichael J Robertson, Brad S Kahl, Julie M Vose, et al.
Blood Advances|January 26, 2022
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapyJurjen Versluis, Manu Pandey, Yael Flamand, et al.
Blood|November 20, 2004
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory responseStefano Monti, Kerry J Savage, Jeffery L Kutok, et al.
Cancer Cell|February 16, 2005
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-AblEllen Weisberg, Paul W Manley, Werner Breitenstein, et al.
American Journal of Hematology|December 25, 2015
Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remissionMatthew D Seftel, Donna Neuberg, Mei-Jie Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibilityJennifer L Shepard, James F Amatruda, Howard M Stern, et al.
JAMA Oncology|February 26, 2016
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and VulvaBrooke E Howitt, Heather H Sun, Margaretha G M Roemer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers NetworkGuray Akturk, Edwin R Parra, Evisa Gjini, et al.
Pageof 36